SLAC National Accelerator Laboratory has upgraded to LCLS-II, featuring a 4 GeV superconducting accelerator composed of 37 cryomodules and two large helium refrigeration systems with a total cooling capacity of 8 kW at 2.0 K. The cryogenic system at SLAC is the successful outcome of a nine-year partnership between SLAC, Fermilab, and Jefferson Lab. This paper highlights the joint efforts between Jefferson Lab and SLAC in the development and implementation of the LCLS-II Cryogenic Plants. It details the project organization, schedule, budget, staffing profile and procurement strategy.
No takes yet. Share an insight, caveat, or question.
Fauve et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: